Cited In for PMID: 26032863

Year	Number of Results
2015	1
2016	3
2017	2
2018	2
2019	9
2020	3
2021	7
2022	6
2023	4
2024	2

1

Prognosis of patients with metastatic renal cell carcinoma and pancreatic metastases.

Kalra S, Atkinson BJ, Matrana MR, Matin SF, Wood CG, Karam JA, Tamboli P, Sircar K, Rao P, Corn PG, Tannir NM, Jonasch E. Kalra S, et al. BJU Int. 2016 May;117(5):761-5. doi: 10.1111/bju.13185. Epub 2015 Jul 6. BJU Int. 2016. PMID: 26032863 Free PMC article.

2

Combining theranostic/particle therapy with immunotherapy for the treatment of GU malignancies.

Skalina KA, Małachowska B, Sindhu KK, Thompson M, Nehlsen AD, Salgado LR, Dovey Z, Hasan S, Guha C, Tang J. Skalina KA, et al. BJUI Compass. 2023 Dec 13;5(3):334-344. doi: 10.1002/bco2.316. eCollection 2024 Mar. BJUI Compass. 2023. PMID: 38481668 Free PMC article. Review.

3

Metabolic alterations in hereditary and sporadic renal cell carcinoma.

Coffey NJ, Simon MC. Coffey NJ, et al. Nat Rev Nephrol. 2024 Apr;20(4):233-250. doi: 10.1038/s41581-023-00800-2. Epub 2024 Jan 22. Nat Rev Nephrol. 2024. PMID: 38253811 Review.

4

Genetic and Epigenetic Characteristics in Isolated Pancreatic Metastases of Clear-Cell Renal Cell Carcinoma.

Sellner F, Compérat E, Klimpfinger M. Sellner F, et al. Int J Mol Sci. 2023 Nov 14;24(22):16292. doi: 10.3390/ijms242216292. Int J Mol Sci. 2023. PMID: 38003482 Free PMC article. Review.

5

Extended Opioid Exposure Modulates the Molecular Metabolism of Clear Cell Renal Cell Carcinoma.

Garige M, Poncet S, Norris A, Chou CK, Wu WW, Shen RF, Greenberg JW, Krane LS, Sourbier C. Garige M, et al. Life (Basel). 2023 May 17;13(5):1196. doi: 10.3390/life13051196. Life (Basel). 2023. PMID: 37240841 Free PMC article.

6

Isolated Pancreatic Metastases of Renal Cell Carcinoma-Clinical Particularities and Seed and Soil Hypothesis.

Sellner F, Thalhammer S, Klimpfinger M. Sellner F, et al. Cancers (Basel). 2023 Jan 4;15(2):339. doi: 10.3390/cancers15020339. Cancers (Basel). 2023. PMID: 36672289 Free PMC article. Review.

7

Renal Cell Carcinoma with Testicular Metastases: A Case Report and Review of the Literature.

Yoshitake S, Shinder BM, Dazen K, Smith C, Mayer TM, Sadimin E, Singer EA. Yoshitake S, et al. J Kidney Cancer VHL. 2022 May 6;9(2):22-26. doi: 10.15586/jkcvhl.v9i2.212. eCollection 2022. J Kidney Cancer VHL. 2022. PMID: 36118790 Free PMC article.

8

The Clinical Significance of Urinary Retinol-Binding Protein 4: A Review.

Ratajczyk K, Konieczny A, Czekaj A, Piotrów P, Fiutowski M, Krakowska K, Kowal P, Witkiewicz W, Marek-Bukowiec K. Ratajczyk K, et al. Int J Environ Res Public Health. 2022 Aug 11;19(16):9878. doi: 10.3390/ijerph19169878. Int J Environ Res Public Health. 2022. PMID: 36011513 Free PMC article. Review.

9

Jagged-1 is induced by mTOR inhibitors in renal cancer cells through an Akt/ALK5/Smad4-dependent mechanism.

Danielpour D, Corum S, Leahy P, Bangalore A. Danielpour D, et al. Curr Res Pharmacol Drug Discov. 2022 Jul 4;3:100117. doi: 10.1016/j.crphar.2022.100117. eCollection 2022. Curr Res Pharmacol Drug Discov. 2022. PMID: 35992379 Free PMC article.

10

Glutaminase inhibition in renal cell carcinoma therapy.

Raczka AM, Reynolds PA. Raczka AM, et al. Cancer Drug Resist. 2019 Jun 19;2(2):356-364. doi: 10.20517/cdr.2018.004. eCollection 2019. Cancer Drug Resist. 2019. PMID: 35582719 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

36 results

Results by year